Accounting Changes and Error Corrections | 2. Restatement of Previously Issued Financial Statements On April 12, 2021, the SEC issued a statement (the “SEC Statement”) on the accounting and reporting considerations for warrants issued by special purpose acquisition companies (“SPAC”). The SEC Statement discussed certain features of warrants issued in SPAC transactions that may be common across many entities. Specifically, the SEC Statement focused in part on provisions in warrant agreements that provide for potential changes to the settlement amounts dependent upon the characteristics of the warrant holder. The SEC Statement indicated that, because the holder of a warrant is not an input into the pricing of a fixed-for-fixed option on equity shares, such provisions would preclude the warrant from being classified in equity and thus the warrant should be classified as a liability. Following consideration of the guidance in the SEC Statement, the Company concluded that its private warrants should be classified as a liability and measured at fair value at each reporting period, rather than as equity awards. Management concluded the effect of this error on the Company’s previously reported condensed consolidated financial statements is material and, as such, the accompanying condensed consolidated financial statements as of February 27, 2021, and the thirteen and twenty-six weeks ended February 27, 2021, and accompanying notes thereto have been restated from the amounts previously reported to give effect to the correction of this error (the “Restatement”). Effects of the Restatement on the Consolidated Balance Sheets as of August 29, 2020, and the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirteen and twenty-six weeks ended February 29, 2020, are presented in the Company’s Amendment No. 1 to Form 10-K (“Form 10-K/A”) for the fiscal year ended August 29, 2020 filed with the SEC on June 30, 2021. Additionally, see Note 13, Earnings (Loss) Per Share, for restated earnings (loss) per share amounts. As a result of the Restatement, the Company’s private warrants (the “Private Warrants”) are now reflected as a liability measured at fair value on the Company’s Condensed Consolidated Balance Sheets, and the change in the fair value of this liability in each period is recognized as a gain or loss in the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The effect of the Restatement on the Condensed Consolidated Balance Sheets as of February 27, 2021, and Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and Condensed Consolidated Statements of Cash Flows for the thirteen and twenty-six weeks ended February 27, 2021, are presented below. Regarding the Condensed Consolidated Statements of Cash Flows, the adjustments below to net income were offset by adjustments to non-cash operating activities within cash flow provided by operations. The Restatement had no effect on total net cash flows from operating, investing or financing activities. The effect of the Restatement on the February 27, 2021 stockholders’ equity balances is presented in the Condensed Consolidated Statements of Stockholders’ Equity below. Condensed Consolidated Balance Sheet February 27, 2021 (In thousands) As Previously Reported Restatement Adjustment As Restated Warrant liability $ — 118,519 $ 118,519 Total liabilities 742,860 118,519 861,379 Additional paid-in-capital 1,098,375 (18,035) 1,080,340 Retained earnings 182,150 (100,484) 81,666 Total stockholders’ equity 1,278,658 (118,519) 1,160,139 Condensed Consolidated Statement of Operations and Thirteen Weeks Ended February 27, 2021 (In thousands) As Previously Reported Restatement Adjustment As Restated Loss in fair value change of warrant liability — (45,334) (45,334) Total other expense (6,908) (45,334) (52,242) Income (loss) before income taxes 26,433 (45,334) (18,901) Net income (loss) 19,120 (45,334) (26,214) Comprehensive income (loss) $ 19,363 $ (45,334) $ (25,971) As a result of the Restatement adjustments, basic earnings per share decreased $0.47, from earnings of $0.20 per share to a loss of $0.27 per share, and diluted earnings per share decreased $0.46, from earnings of $0.19 per share to a loss of $0.27 per share. Condensed Consolidated Statement of Operations and Twenty-Six Weeks Ended February 27, 2021 (In thousands) As Previously Reported Restatement Adjustment As Restated Loss in fair value change of warrant liability — (24,881) (24,881) Total other expense (15,221) (24,881) (40,102) Income before income taxes 57,307 (24,881) 32,426 Net income 41,620 (24,881) 16,739 Comprehensive income $ 41,818 $ (24,881) $ 16,937 As a result of the Restatement adjustments, basic earnings per share decreased $0.26, from earnings of $0.43 per share to $0.17 per share, and diluted earnings per share decreased $0.24, from earnings of $0.41 per share to $0.17 per share. Twenty-Six Weeks Ended Condensed Consolidated Statement of Cash Flows February 27, 2021 (In thousands) As Previously Reported Restatement Adjustment As Restated Operating activities Net income $ 41,620 $ (24,881) $ 16,739 Adjustments to reconcile net income to net cash provided by operating activities: Loss in fair value change of warrant liability — 24,881 24,881 Net cash provided by operating activities $ 39,764 $ — $ 39,764 Condensed Consolidated Statement of Stockholders’ Equity February 27, 2021 (In thousands) As Previously Reported Restatement Adjustment As Restated Additional paid-in-capital $ 1,098,375 $ (18,035) $ 1,080,340 Net income 41,620 (24,881) 16,739 Retained earnings 182,150 (100,484) 81,666 Total stockholders’ equity $ 1,278,658 $ (118,519) $ 1,160,139 |